<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000599961">
  <TermName>ammonium tetrathiomolybdate</TermName>
  <TermPronunciation>(uh-MOH-nee-um TEH-truh-THY-oh-muh-LIB-dayt)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of many types of cancer. Ammonium tetrathiomolybdate removes extra copper from the body. Removing the copper may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. Ammonium tetrathiomolybdate is a type of chelating agent and a type of antiangiogenesis agent.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000721197" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ammonium tetrathiomolybdate&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000721198" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tetratiomolibdato de amonio&quot;" language="es" id="_4"/>
  <SpanishTermName>tetratiomolibdato de amonio</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de muchos tipos de cáncer. El tetratiomolibdato de amonio elimina el exceso de cobre en el cuerpo, lo que quizás prevenga la formación de vasos sanguíneos nuevos que los tumores necesitan para crecer y destruya células cancerosas. El tetratiomolibdato de amonio es un tipo de quelante y de antiangiogénico.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2008-07-14</DateFirstPublished>
  <DateLastModified>2009-04-21</DateLastModified>
</GlossaryTerm>
